CVRx (CVRX) Cash from Operations Growth (5y) (2025 - 2026)

CVRx (CVRX) Cash from Operations Growth (5y) (2025 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	183.13 Bn	175.83 Bn	6.27 Bn
2	Stryker	128.75 Bn	125.88 Bn	3.81 Bn
3	Medtronic	108.98 Bn	99.76 Bn	6.41 Bn
4	Boston Scientific	68.45 Bn	67.00 Bn	3.61 Bn
5	Edwards Lifesciences	48.01 Bn	44.34 Bn	1.29 Bn
6	GE HealthCare Technologies	28.29 Bn	26.01 Bn	1.98 Bn
7	Dexcom	28.25 Bn	27.13 Bn	750.30 Mn
8	Smith & Nephew	26.91 Bn	26.33 Bn	-
9	Koninklijke Philips	25.45 Bn	22.32 Bn	2.07 Bn
10	CVRx	129.41 Mn	57.10 Mn	12.88 Mn

Download Data